-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A+Oc+NBXHRCbemBiKD3+wlUxSO4yrVG768XRjjLz+aTaj0pW4/OQStiyxH6pLwon 0fLUDQecWefluQyhRbHMGg== 0001193125-06-169121.txt : 20060810 0001193125-06-169121.hdr.sgml : 20060810 20060810140435 ACCESSION NUMBER: 0001193125-06-169121 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060724 ITEM INFORMATION: Other Events FILED AS OF DATE: 20060810 DATE AS OF CHANGE: 20060810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SONTRA MEDICAL CORP CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23017 FILM NUMBER: 061020687 BUSINESS ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 BUSINESS PHONE: 508 553-8850 MAIL ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC /MN/ DATE OF NAME CHANGE: 19970625 8-K/A 1 d8ka.htm FORM 8-K AMENDMENT NO. 1 Form 8-K Amendment No. 1

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 8-K/A

 


AMENDMENT NO. 1 TO

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 24, 2006

 


SONTRA MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Minnesota   000-23017   41-1649949

(State or other jurisdiction of

incorporation)

  (Commission File No.)  

(IRS Employer

Identification No.)

 

10 Forge Parkway Franklin, Massachusetts   02038
(Address of principal executive offices)   (Zip Code)

(508) 553-8850

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Explanatory Note

Sontra Medical Corporation (the “Company”) is filing this Amendment No. 1 on Form 8-K/A to its Current Report on Form 8-K dated July 24, 2006, as filed with the SEC on July 27, 2006 (the “Original Current Report”) to correct and restate the second sentence under Item 8.01 to disclose that the number of authorized shares of Common Stock will remain unchanged after the reverse stock split is effective.

Item 8.01 Other Events.

The second sentence of Item 8.01 of the Original Current Report is hereby deleted in its entirety and replaced with the following: Pursuant to the Reverse Stock Split, each ten shares of Common Stock of the Company will be combined and reclassified into one share of Common Stock of the Company, and the number of issued and outstanding shares of Common Stock of the Company will be proportionally reduced, in both cases without any change to the authorized number of shares of Common Stock or the par value of such shares.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Sontra Medical Corporation
Date: August 10, 2006   By:  

/s/ Thomas W. Davison

    Thomas W. Davison
    President and Chief Executive Officer
-----END PRIVACY-ENHANCED MESSAGE-----